Introduction symptoms 1) . In Japan, the traditional medication Yukgunja-tang (YGJT, Rikkunshito, Liujunzi) has been approved for medicinal use, and is widely used to treat patients with upper gastrointestinal (GI) symptoms 4) .
Although YGJT is used for clinical treatment of GERD in China and Japan and related clinical studies are underway, only random studies on the effects of YGJT on functional dyspepsia 5) and in animal models 6) have been conducted in Korea.
Therefore, the aim of this meta-analysis was to systematically review the efficacy and safety of YGJT when used to treat GERD.
Methods

Data Sources and Search Strategy
The following electronic databases were searched to identify relevant studies uploaded through 
4) Types of Comparisons
We included all types of control intervention, including placebo and conventional medication.
Outcome Measures
Outcomes were assessed using efficacies, 
Data Synthesis
The statistical analysis was conducted using 
Description of the Included Trials
A total of 240 studies were originally identified by searching 16 databases using search terms and search strategies. Of these, 108 were excluded for duplication. The remaining 132 studies were reviewed with a focus on titles and abstracts, and 67 were primarily excluded. Subsequently, another 52 studies were excluded for the following reasons: 25 articles could not find the full text, 15
were not randomized, 2 did not include a clinical trial, 6 did not discuss GERD, and 4 did not use YGJT. Finally, 13 studies were selected, and 11
were included in the meta-analysis. The flow chart of the selection process is provided in Figure 1 .
Characteristic data from the 13 studies are summarized in Table 1 . Table 2 .
Risk of Bias
All studies were described as 'randomized', but only seven studies reported the method of random sequence generation. Three studies described allocation concealments. Eleven studies had high risks of bias for participant and personnel blinding, and two studies had low risk. Only one trial used outcome assessment blinding. All (558) included studies reported complete outcome data.
Results
All studies had a low risk of selective reporting bias; four studies were published protocols and nine studies included all expected outcomes ( Figure 2, 3 ).
Outcome Measurements
YGJT plus PPI versus double-dose PPI and YGJT versus YGJT plus PPI were excluded from the meta-analysis because these were conducted in one study each. YGJT group, but the GSRS score did not show a statistically significant difference in the two studies.
1) YGJT versus Placebo
2) YGJT versus Conventional Medicine
Nine [11] [12] [13] [14] [15] [16] [17] [18] [19] studies on YGJT and conventional medicine included improvements in symptom scores and suggested effects of the treatment for each symptom; these comprised 918 patients (460 in the YGJT groups and 458 in the conventional medicine groups). In two studies, scores for each symptom were presented. Symptoms included heartburn, acid regurgitation, sternalgia, and reflux. Four studies reported efficacy under gastroscopy, but one study was excluded because its scoring criteria differed from those used in the three other studies 12, 15, 17) . In one study, reflux symptom scores were excluded from the meta-analysis. in only one study each, so we could not analyze their effects. ( Figure 6 ). (Figure 7) .
3) Recurrence Rate
Three of the 13 studies mentioned recurrence rate; recurrences occurred between one and ten months after treatment completion. Although the forest plot showed possible statistical heterogeneity (I² = 33%), the recurrence rate was significantly (Figure 8 ).
4) Adverse Effects
Six studies reported adverse effects during the treatment. Of these, four studies reported no significant adverse effects . In one study, nausea, mild cough, dizziness, and diarrhea were reported in both the YGJT group and the conventional medicine group. One study mentioned the number of patients that experienced adverse effects, and eight patients administered conventional medicine reported headache or constipation. In all cases, symptoms disappeared after treatment cessation and did not affect outcomes.
GERD is defined as a condition that develops when reflux of stomach contents causes troublesome symptoms and/or complications. Clinically troublesome 
